Journal
BIOMOLECULES
Volume 12, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/biom12040536
Keywords
homocysteine; vitamin B6; folic acid; myocardial infarction; heart failure; experimental models
Categories
Ask authors/readers for more resources
Cardiovascular diseases are primarily caused by homocysteine, with Vitamin B6 playing a significant role in its metabolism. Deficiency in Vitamin B6 may lead to hyperhomocysteinemia, damaging the blood vessel wall and worsening atherosclerosis.
Cardiovascular diseases are the leading cause of death and the main cause of disability. In the last decade, homocysteine has been found to be a risk factor or a marker for cardiovascular diseases, including myocardial infarction (MI) and heart failure (HF). There are indications that vitamin B6 plays a significant role in the process of transsulfuration in homocysteine metabolism, specifically, in a part of the reaction in which homocysteine transfers a sulfhydryl group to serine to form alpha-ketobutyrate and cysteine. Therefore, an elevated homocysteine concentration (hyperhomocysteinemia) could be a consequence of vitamin B6 and/or folate deficiency. Hyperhomocysteinemia in turn could damage the endothelium and the blood vessel wall and induce worsening of atherosclerotic process, having a negative impact on the mechanisms underlying MI and HF, such as oxidative stress, inflammation, and altered function of gasotransmitters. Given the importance of the vitamin B6 in homocysteine metabolism, in this paper, we review its role in reducing oxidative stress and inflammation, influencing the functions of gasotransmitters, and improving vasodilatation and coronary flow in animal models of MI and HF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available